Prof Gemma Figtree is committed to improving the care for heart attack patients, using her knowledge of redox signalling to develop methods of identifying those at highest risk of adverse outcomes, and discovering novel therapies, inspired by her clinical work as an interventional cardiologist at Royal North Shore Hospital.
Dr Neila Likouhi is a doctor in the cardiology department at Royal North Shore hospital.
Associate Professor Rebecca Kozor is a consultant cardiologist and clinician researcher at Royal North Shore Hospital Sydney and the University of Sydney, with specialist expertise in cardiac imaging, including cardiovascular magnetic resonance (CMR), cardiac CT, and echocardiography.
Dr Hari Sritharan is leveraging AI and Machine learning to improve clinical decision making and patient care
Dr Karan Rao is looking at a method to reliably predict patients at risk of heart block following their TAVI.
Dr Gianotti is working on The NARNIA study, using new scan technology to identify early risk factors for a heart attack and cardiovascular disease.
Dr Ashleigh Dind’s latest research is focused on better understanding the differences between myocarditis (inflammation of the heart muscle) and myocardial infarction (commonly known as heart attack).
Dr Avedis Ekmejian’s research is looking at the mechanisms which could cause varying results between FFR and iFR, and how these differences can be interpreted. He will also look at the makeup and geometry of the plaque itself using intra-vascular imaging (OCT). He will look at whether increased irregularity and surface roughness within the lesion or plaque itself is accounting for these differences.
Angus Fung is researching existing body size metrics to establish a definitive metric for the indexation of cardiac output, heart rate and stroke volumes, and empirically determining a cut-off value for these measures utilising The National Echo Database Australia, the largest database of its type in the world.
Dr Eveline Staub is a specialist in general paediatrics, neonatology and paediatric intensive care. Dr Staub is currently a consultant neonatologist at Royal North Shore Hospital, NSW, focusing on clinical work with patients and families, researching the development of kidneys after preterm birth and the long-term consequences on blood pressure and renal health.
Dr Allahwala has a keen interest in coronary artery disease, valvular heart disease, heart failure management and arrhythmias. He has a strong background in research having published more than 30 peer reviewed journal articles and book chapters.
Professor Ugander has a research interest in non-invasive cardiac imaging in general and cardiac magnetic resonance imaging (MRI) in particular, with a focus on the diagnoses ischemic heart disease, myocarditis, and heart failure, as well as basic cardiac pumping physiology.
Dr Gentile’s work focuses on cardiovascular regeneration and tissue engineering for heart attack. Dr Carmine’s current research involves working closely with cardiologists and cardiac surgeons to identify the best way to provide 3D bio-printed heart tissue for a patient who has suffered a heart attack.
As Laboratory Manager, Dr Tang is a key figure in the lab, sharing his knowledge and expertise with graduate students and medical researchers.
Professor Kluckow is a Senior Staff Specialist in Neonatology at Royal North Shore Hospital in Sydney and a Professor of Neonatology at the University of Sydney, Australia. With his Sydney based research group, he has led the development of neonatal haemodynamics and point of care ultrasound in the neonatal unit for the past 23 years,
Professor Geoffrey Tofler has over 20 years’ experience as a clinical consultant cardiologist, including 13 years at Harvard Medical School Hospital in Boston.
Professor Helge Rasmussen divides his time between working as an interventional cardiologist and leading a team of researchers in molecular and cellular medicine. A particular focus of his research is learning how heart cells work, which has led to discoveries that could mean better treatment for heart failure and other forms of cardiovascular disease.